Collagen
Collagen is the most abundant structural protein in the extracellular matrix of animals and a central determinant of tissue architecture, tensile strength, and mechanical signaling.
Collagen is the most abundant structural protein in the extracellular matrix of animals and a central determinant of tissue architecture, tensile strength, and mechanical signaling. It forms fibrillar and non-fibrillar networks that support skin, bone, tendon, vessel walls, and many internal organs. Beyond its structural role, collagen influences cell adhesion, migration, differentiation, wound repair, fibrosis, and tumor behavior through interactions with integrins and other matrix receptors, thereby affecting pathways such as FAK/MAPK mechanotransduction and epithelial-mesenchymal transition (EMT).
In biomedical research, collagen is studied both as a native matrix component and as a biomaterial. It is widely used in hydrogels, membranes, films, bioinks, decellularized scaffolds, and composite delivery systems because of its biocompatibility and bioactivity. At the same time, excessive collagen deposition, cross-linking, or remodeling is implicated in fibrosis, tumor stroma stiffening, and age-related tissue dysfunction, making collagen a frequent target in studies of cancer, wound healing, cardiovascular disease, and regenerative medicine.
Where the papers sit
12 papers from the last 6 months study collagen directly · updated from PubMed 12 Oct 2026
Study type 0 clinical trials · 1 human data · 11 preclinical
Themes 3 themes · 1 paradigm shift · 1 new direction
-
Collagen-Based Skin Repair
Collagen-rich hydrogels and bioinks aim to rebuild skin and close difficult wounds while controlling the local microenvironment. Collagen/hyaluronic acid/chitosan supports hemostasis and infected-wound healing, while photocurable collagen enables printed diabetic-wound repair. Other approaches target dermal fibroblasts with trans-amplifying RNA or deliver collagen transdermally for matrix regeneration and aging-skin rejuvenation. Janus hydrogels extend the platform to sweat-glucose and motion sensing, so therapeutic repair and monitoring remain only partly integrated.
6 papers · 50%
-
Scaffolds for Tissue Regeneration
Biomaterial scaffolds are being used to couple extracellular cues with cell- and exosome-based tissue repair. Injury-preconditioned hUCMSC exosomes support neuroprotection and neuroregeneration in 3D brain constructs, while macrophage exosomes reduce mesenchymal-stem-cell senescence. Fibroin, PCL/nHA/SA/COL and airway extracellular-matrix bioinks extend this strategy across neural, bone and airway repair. The shared direction is toward biomimetic printed constructs, although functional tissue maturation remains an open challenge.
3 papers · 25%
-
Collagen and Tumor Immunity
Collagen is being treated as both a barrier to antitumor immunity and a measurable feature of tumor biology. ITGA2 blockade remodels the breast-cancer microenvironment and improves anti-PD-L1 activity, while ADAMTS1-driven collagenolysis reverses castration resistance and immunosuppression. Digital pathology links intratumoral collagen with pituitary neuroendocrine tumors, supporting its use as a context-dependent biomarker. The work is moving toward collagen-aware immunotherapy and stratification, but whether collagen depletion or specific integrin targeting benefits patients remains open.
3 papers · 25%
Collagen-rich stroma is an active driver of immune suppression and treatment resistance, not merely a structural tumor feature
The 4T1 breast cancer model studied integrin α2 blockade, while castration-resistant prostate cancer studied dual DNMT/EZH2 inhibition that reactivates ADAMTS1 collagenolysis. In the breast cancer model, disrupting the collagen I/IV receptor CD49b reduced tumor growth, increased CD8+ T-cell and dendritic-cell infiltration, and depleted immunosuppressive myeloid populations 42747603Sep. Independently, in prostate cancer, restoring ADAMTS1-mediated degradation of collagen-rich stroma suppressed FAK/MAPK mechanotransduction and epithelial–mesenchymal transition while reversing immunosuppression 42313934Jun. Together, these findings replace the set’s predominantly structural or supportive view of collagen with a causal stromal mechanism whose receptor-mediated engagement or persistence can sustain immune exclusion, therapy resistance, and tumor progression.
Collagen serves as a self-healing, skin-affine layer in a wearable biosensor rather than as a regenerative scaffold or tissue-repair matrix
The anti-freezing Janus hydrogel for sweat-glucose and motion monitoring uses a Collagen-PVA layer as part of a wearable device. Rather than supplying an extracellular-matrix scaffold for tissue repair, this collagen-containing layer exploits dynamic hydrogen bonds and physical entanglements to provide 87.5% self-healing efficiency and skin affinity, while the adjacent layer performs sweat-glucose sensing at subzero temperatures 42480214Jul. This assigns collagen a device-engineering role in durable, antifreezing wearable biosensing that is distinct from the regenerative and structural biomaterial roles represented elsewhere in the set.
Papers
The 12 papers from the last 6 months that study collagen directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Collagen-Based Skin Repair (6)
- Mechanical cues of an interpenetrating polysaccharide matrix regulate self-assembly of collagen fibers. Science advances · 2 Sept 2026 PMID 42685201
- A Dual-Crosslinked Collagen/Hyaluronic Acid/Chitosan Hydrogel for Integrated Hemostasis and Infected Wound Healing. ACS biomaterials science & engineering · 19 Aug 2026 PMID 42615380
- Photocurable Allyl-Succinylated Collagen Bioink for High-Resolution 3D Bioprinting and Regenerative Diabetic Wound Healing. ACS biomaterials science & engineering · 16 Aug 2026 PMID 42604869
- Anti-Freezing Janus Hydrogels for Non-Invasive Sweat Glucose and Motion Monitoring in Subzero Environments. Langmuir : the ACS journal of surfaces and colloids · 21 Jul 2026 PMID 42480214
- Breaching the Skin Barrier: Efficient Transdermal Delivery of Natural Collagen for Aging Skin Rejuvenation. Langmuir : the ACS journal of surfaces and colloids · 5 Jun 2026 PMID 42246872
- Dermal fibroblast-targeted trans-amplifying RNA nanotherapeutics for skin extracellular matrix regeneration. Journal of controlled release : official journal of the Controlled Release Society · 23 Apr 2026 PMID 42025772
Scaffolds for Tissue Regeneration (3)
- 3D-printed biomimetic scaffolds integrated with exosomes from injury-preconditioned hUCMSCs promote brain tissue repair via neuroprotection and neurogenesis. Journal of materials chemistry. B · 25 Aug 2026 PMID 42638487
- 3D-printed PCL/nHA/SA/COL loaded with M2 macrophage-derived exosomes alleviates the senescence of bone marrow mesenchymal stem cells. International immunopharmacology · 11 Jun 2026 PMID 42275920
- Airway mucosa-derived extracellular matrix bioink for 3D bioprinting of functional airway tissue. Biofabrication · 24 Apr 2026 PMID 42030975
Collagen and Tumor Immunity (3)
- Integrin α2 (CD49b) blockade remodels the tumor immune microenvironment and enhances anti-PD-L1 therapy in 4T1 breast cancer model. Breast cancer research and treatment · 16 Sept 2026 PMID 42747603
- Targeting the DNA methylation-H3K27me3 switch reverses castration resistance and immunosuppression via ADAMTS1-driven collagenolysis. Proceedings of the National Academy of Sciences of the United States of America · 18 Jun 2026 PMID 42313934
- Assessment of intratumoral collagen in pituitary neuroendocrine tumors (pituitary adenomas/PitNets) via digital pathology and its correlation with intraoperative consistency. Pituitary · 23 May 2026 PMID 42177361
By study type
Human data, design not indexed (1)
- Assessment of intratumoral collagen in pituitary neuroendocrine tumors (pituitary adenomas/PitNets) via digital pathology and its correlation with intraoperative consistency. Pituitary · 23 May 2026 PMID 42177361
Preclinical: animal, cell and lab studies (11)
- Integrin α2 (CD49b) blockade remodels the tumor immune microenvironment and enhances anti-PD-L1 therapy in 4T1 breast cancer model. Breast cancer research and treatment · 16 Sept 2026 PMID 42747603
- Mechanical cues of an interpenetrating polysaccharide matrix regulate self-assembly of collagen fibers. Science advances · 2 Sept 2026 PMID 42685201
- 3D-printed biomimetic scaffolds integrated with exosomes from injury-preconditioned hUCMSCs promote brain tissue repair via neuroprotection and neurogenesis. Journal of materials chemistry. B · 25 Aug 2026 PMID 42638487
- A Dual-Crosslinked Collagen/Hyaluronic Acid/Chitosan Hydrogel for Integrated Hemostasis and Infected Wound Healing. ACS biomaterials science & engineering · 19 Aug 2026 PMID 42615380
- Photocurable Allyl-Succinylated Collagen Bioink for High-Resolution 3D Bioprinting and Regenerative Diabetic Wound Healing. ACS biomaterials science & engineering · 16 Aug 2026 PMID 42604869
- Anti-Freezing Janus Hydrogels for Non-Invasive Sweat Glucose and Motion Monitoring in Subzero Environments. Langmuir : the ACS journal of surfaces and colloids · 21 Jul 2026 PMID 42480214
- Targeting the DNA methylation-H3K27me3 switch reverses castration resistance and immunosuppression via ADAMTS1-driven collagenolysis. Proceedings of the National Academy of Sciences of the United States of America · 18 Jun 2026 PMID 42313934
- 3D-printed PCL/nHA/SA/COL loaded with M2 macrophage-derived exosomes alleviates the senescence of bone marrow mesenchymal stem cells. International immunopharmacology · 11 Jun 2026 PMID 42275920
- Breaching the Skin Barrier: Efficient Transdermal Delivery of Natural Collagen for Aging Skin Rejuvenation. Langmuir : the ACS journal of surfaces and colloids · 5 Jun 2026 PMID 42246872
- Airway mucosa-derived extracellular matrix bioink for 3D bioprinting of functional airway tissue. Biofabrication · 24 Apr 2026 PMID 42030975
- Dermal fibroblast-targeted trans-amplifying RNA nanotherapeutics for skin extracellular matrix regeneration. Journal of controlled release : official journal of the Controlled Release Society · 23 Apr 2026 PMID 42025772
Written from 12 PubMed abstracts, each one listed by PMID above. Published: 2026-07-11. Last written: 2026-09-18 by GPT. Drafted by language models from published abstracts; not medical advice.